Soc. Generale Call 4.25 CABK 20.1.../ DE000SU9L2L5 /
29.05.2024 8:11:04 | Изменение+0.02 | Бид12:40:15 | Предложение12:40:15 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
1.13EUR | +1.80% | 1.13 Величина цены спроса: 40,000 |
1.14 Величина цены предложения: 40,000 |
CAIXABANK CAIXABANK,... | 4.25 EUR | 20.12.2024 | Call |
GlobeNewswire
13:02
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
13:00
Host Hotels & Resorts Enters into Agreement to Acquire Turtle Bay Resort in Hawaii
GlobeNewswire
13:00
Kynexis Appoints Esteemed Scientific Advisory Board Members to Advance Precision Therapeutics for Br...
GlobeNewswire
13:00
Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, ...
GlobeNewswire
13:00
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezata...
GlobeNewswire
13:00
Predictive Oncology Announces CEO Raymond Vennare to Present at the BIO International Convention 202...
GlobeNewswire
13:00
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function ...
GlobeNewswire
13:00
Fractyl Health to Present New Preclinical Obesity Data from Rejuva® Platform at the American Diabete...
GlobeNewswire
13:00
TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its ...
GlobeNewswire
13:00
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница